Adial Pharmaceuticals publishes Phase 3 ONWARD study results in the European Journal of Internal Medicine. The study reveals AD04 significantly reduces heavy drinking days, with adverse events matching the placebo.
"Sell in May and Walk Away." This age-old Wall Street adage, in addition to the stock market, has proven increasingly applicable to cryptocurrencies as well.
From June to August, market growth and trading volumes have historically trended down across the sector.
Eli Lilly & Co has intensified its fight against counterfeit versions of its popular obesity drug, Zepbound, by initiating additional legal proceedings against companies selling compounded versions of the medication.
XPeng CEO tests Tesla's full self-driving software in the US, invites comparisons with XPeng's XNGP, amid company's new product launches and market developments.
US stock markets closed higher on Tuesday with S&P 500 and Nasdaq reaching record highs. Nvidia became world's most valuable company. Asian markets mixed.